BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CD274, PDL1, 29126, ENSG00000120217, PDCD1L1, PD-L1, MGC142296, PDCD1LG1, MGC142294, B7H1, Q9NZQ7, B7-H AND Prognosis
67 results:

  • 1. A novel TCGA-validated programmed cell-death-related signature of ovarian cancer.
    Cai X; Lin J; Liu L; Zheng J; Liu Q; Ji L; Sun Y
    BMC Cancer; 2024 Apr; 24(1):515. PubMed ID: 38654239
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Whole-genome CRISPR screening identifies molecular mechanisms of pd-l1 expression in adult T-cell leukemia/lymphoma.
    Chiba M; Shimono J; Suto K; Ishio T; Endo T; Goto H; Hasegawa H; Maeda M; Teshima T; Yang Y; Nakagawa M
    Blood; 2024 Apr; 143(14):1379-1390. PubMed ID: 38142436
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification and validation of necroptosis-related gene signatures to predict clinical outcomes and therapeutic responses in acute myeloid leukemia.
    Wen XM; Xu ZJ; Ma JC; Xia PH; Jin Y; Chen XY; Qian W; Lin J; Qian J
    Aging (Albany NY); 2023 Nov; 15(24):14677-14702. PubMed ID: 37993258
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Exosomal circRNA-001264 promotes AML immunosuppression through induction of M2-like macrophages and pd-l1 overexpression.
    Du A; Yang Q; Sun X; Zhao Q
    Int Immunopharmacol; 2023 Nov; 124(Pt A):110868. PubMed ID: 37657244
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Determination of Cuproptosis-related Subtypes, Development of a Prognostic Model, and Characterization of Tumor Microenvironment Infiltration in Acute Myeloid leukemia.
    Tao Y; Ren J; Xue T; Wang Y; Xu H; Zhang H; Lu J
    Anticancer Res; 2023 Sep; 43(9):3943-3960. PubMed ID: 37648328
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Increased PD-1 expression of bone marrow T-cells in acute myeloid leukaemia patients after stem cell transplantation, and its association with overall survival.
    You E; Park CJ; Cho YU; Jang S; Lee MY; Kim H; Koh KN; Im HJ; Choi EJ; Lee JH; Lee KH
    Ann Clin Biochem; 2024 Mar; 61(2):79-89. PubMed ID: 37314798
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Association of CDKN2A/B mutations, PD-1, and pd-l1 with the risk of acute lymphoblastic leukemia in children.
    Ruan Y; Xie L; Zou A
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10841-10850. PubMed ID: 37314514
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. pd-l1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia.
    Soltani M; Ghanadian M; Ghezelbash B; Shokouhi A; Zamyatnin AA; Bazhin AV; Ganjalikhani-Hakemi M
    BMC Cancer; 2023 May; 23(1):447. PubMed ID: 37193972
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis.
    Berning P; Schmitz N; Ngoya M; Finel H; Boumendil A; Wang F; Huang XJ; Hermine O; Philippe L; Couronné L; Jaccard A; Liu D; Wu D; Reinhardt HC; Chalandon Y; Wagner-Drouet E; Kwon M; Zhang X; Carpenter B; Yakoub-Agha I; Wulf G; López-Jiménez J; Sanz J; Labussière-Wallet H; Shimoni A; Dreger P; Sureda A; Kim WS; Glass B
    Leukemia; 2023 Jul; 37(7):1511-1520. PubMed ID: 37157017
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and simultaneously improves immunity.
    Fitzel R; Secker-Grob KA; Keppeler H; Korkmaz F; Schairer R; Erkner E; Schneidawind D; Lengerke C; Hentrich T; Schulze-Hentrich JM; Schneidawind C
    Neoplasia; 2023 Jul; 41():100902. PubMed ID: 37148657
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. pd-l1 and MCL-1 markers and the relationship with prognostic characteristics of differentiated thyroid carcinoma.
    Zantut-Wittmann DE; Barreto IS; Laus AC; Moreno DA; Moma CA; Maia FFR; Assumpção LVMD; Reis RM
    Mol Cell Endocrinol; 2023 Jun; 570():111931. PubMed ID: 37072108
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Establishment and comprehensive analysis of a new human cell line (NK-NJ) with NK-cell characteristics established from extranodal natural killer cell lymphoma/leukemia.
    Liang JH; Wang WT; Du KX; Xing TY; Wang Y; Wang H; Liu L; Guo R; Shao Y; Liang J; Li Y; Shen HR; Wang L; Li JY; Xu W
    Hum Cell; 2023 Mar; 36(2):835-846. PubMed ID: 36520345
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape.
    Mangolini M; Maiques-Diaz A; Charalampopoulou S; Gerhard-Hartmann E; Bloehdorn J; Moore A; Giachetti G; Lu J; Roamio Franklin VN; Chilamakuri CSR; Moutsopoulos I; Rosenwald A; Stilgenbauer S; Zenz T; Mohorianu I; D'Santos C; Deaglio S; Hodson DJ; Martin-Subero JI; Ringshausen I
    Nat Commun; 2022 Oct; 13(1):6220. PubMed ID: 36266281
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Dynamics of PD-1 expression are associated with treatment efficacy and prognosis in patients with intermediate/high-risk myelodysplastic syndromes under hypomethylating treatment.
    Geng S; Xu R; Huang X; Li M; Deng C; Lai P; Wang Y; Wu P; Chen X; Weng J; Du X
    Front Immunol; 2022; 13():950134. PubMed ID: 36003379
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor Microenvironment.
    Zhang T; Liu H; Gao F; Gong W; Cui Y; He J; Li L; Qiu L; Qian Z; Zhou S; Meng B; Ren X; Zhang H; Wang X
    Front Immunol; 2022; 13():922471. PubMed ID: 35734168
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Bioinformatics analyses proposed xenotropic and polytropic retrovirus receptor 1 as a potential diagnostic and prognostic biomarker and immunotherapeutic target in head and neck squamous cell carcinoma.
    Wang L
    Auris Nasus Larynx; 2023 Feb; 50(1):134-150. PubMed ID: 35690506
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Expression of pd-l1 on regulatory B cells in patients with acute myeloid leukaemia and its effect on prognosis.
    Shi Y; Liu Z; Wang H
    J Cell Mol Med; 2022 Jun; 26(12):3506-3512. PubMed ID: 35610758
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A bibliometric analysis of diffuse large B-cell lymphoma research from 2001 to 2020.
    Jiang J; Lyu W; Chen N
    Comput Biol Med; 2022 Jul; 146():105565. PubMed ID: 35594683
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Systematic analysis of prognostic significance, functional enrichment and immune implication of STK10 in acute myeloid leukemia.
    Bi L; Jia S; Hu W; Su X; Chen X; Tang H
    BMC Med Genomics; 2022 May; 15(1):101. PubMed ID: 35501867
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Immune-related gene signature predicts clinical outcomes and immunotherapy response in acute myeloid leukemia.
    Xu Q; Cao D; Fang B; Yan S; Hu Y; Guo T
    Cancer Med; 2022 Sep; 11(17):3364-3380. PubMed ID: 35355427
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.